Chiller, Tom

Coccidioidomycosis Acquired in Washington State

Marsden-Haug, N., Goldoft, M., Ralston, C., Limaye, A. P., Chua, J., Hill, H., Jecha, L., Thompson, G. R., & Chiller, T. (2013) · Clinical Infectious Diseases

Fungal Infections and StudiesActinomycetales infections and treatment

Cited by 126

CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis

Ford, N., Shubber, Z., Jarvis, J. N., Chiller, T., Greene, G., Migone, C., Vitoria, M., Doherty, M., & Meintjes, G. (2018) · Clinical Infectious Diseases

Fungal Infections and StudiesPneumocystis jirovecii pneumonia detection and treatment

Cited by 113

Epidemiology of Invasive Candidiasis

Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 109

Notes from the Field: Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021

Lyman, M., Forsberg, K., Reuben, J., Dang, T., Free, R., Seagle, E. E., Sexton, D. J., Soda, E., Jones, H., Hawkins, D., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 104

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries

Loyse, A., Burry, J., Cohn, J., Ford, N., Chiller, T., Ribeiro, I., Koulla-Shiro, S., Mghamba, J., Ramadhani, A., Nyirenda, R., et al. (2019) · The Lancet Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 90

Mycotic Infections Acquired outside Areas of Known Endemicity, United States

Benedict, K., Thompson, G. R., Deresinski, S., & Chiller, T. (2015) · Emerging Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 89

Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015

Benedict, K., Roy, M., Kabbani, S., Anderson, E. J., Farley, M. M., Harb, S., Harrison, L. H., Bonner, L., Wadu, V. L., Marceaux, K., et al. (2018) · Journal of the Pediatric Infectious Diseases Society

Antifungal resistance and susceptibilityNeonatal and Maternal Infections

Cited by 81

Trends in Candida Central Line-Associated Bloodstream Infections Among NICUs, 1999–2009

Chitnis, A. S., Magill, S. S., Edwards, J. R., Chiller, T. M., Fridkin, S. K., & Lessa, F. C. (2012) · Pediatrics

Antifungal resistance and susceptibilityCentral Venous Catheters and Hemodialysis

Cited by 78

Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris

Lockhart, S. R., Jackson, B. R., Vallabhaneni, S., Ostrosky-Zeichner, L., Pappas, P. G., & Chiller, T. (2017) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 61

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017

Zhang, A. Y., Shrum, S., Williams, S., Petnic, S., Nadle, J., Johnston, H., Barter, D., Vonbank, B., Bonner, L., Hollick, R., et al. (2020) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 54

Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis

Chang, D. C., Burwell, L. A., Lyon, G. M., Pappas, P. G., Chiller, T. M., Wannemuehler, K. A., Fridkin, S. K., & Park, B. J. (2008) · Infection Control & Hospital Epidemiology

Antifungal resistance and susceptibilityMedical Coding and Health Information

Cited by 51

Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020–December 2021

Gold, J. A. W., Adjei, S., Gundlapalli, A. V., Huang, Y.-L. A., Chiller, T., Benedict, K., & Toda, M. (2023) · Emerging Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 43

Notes from the Field: Surveillance for Candida auris — Colombia, September 2016–May 2017

Escandón, P., Cáceres, D. H., Espinosa-Bode, A., Rivera, S., Armstrong, P., Vallabhaneni, S., Berkow, E. L., Lockhart, S. R., Chiller, T., Jackson, B. R., et al. (2018) · MMWR. Morbidity and Mortality Weekly Report

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 42

Emerging multidrug-resistant Candida duobushaemulonii infections in Panama hospitals: importance of laboratory surveillance and accurate identification.

Ramos, R., Caceres, D. H., Perez, M., Garcia, N., Castillo, W., Santiago, E., Borace, J., Lockhart, S. R., Berkow, E. L., Hayer, L., et al. (2018) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 32

Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance

Deak, E., Etienne, K. A., Lockhart, S. R., Gade, L., Chiller, T., & Balajee, S. A. (2010) · Canadian Journal of Microbiology

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 29

Candida auris: An Emerging Antimicrobial Resistance Threat

Vallabhaneni, S., Jackson, B. R., & Chiller, T. M. (2019) · Annals of Internal Medicine

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 25

Risk Stratification With Coccidioidal Skin Test to Prevent Valley Fever Among Inmates, California, 2015.

Wheeler, C., Lucas, K. D., Derado, G., McCotter, O., Tharratt, R. S., Chiller, T., & Mohle-Boetani, J. C. (2018) · Journal of Correctional Health Care

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 17

Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States

Walker, T. A., Lockhart, S. R., Beekmann, S. E., Polgreen, P. M., Santibanez, S., Mody, R. K., Beer, K. D., Chiller, T. M., & Jackson, B. R. (2018) · Emerging Infectious Diseases

Antifungal resistance and susceptibilityAntibiotic Use and Resistance

Cited by 13

1722. The changing epidemiology of candidemia in the United States: injection drug use as an emerging risk factor for candidemia

Zhang, A. Y., Shrum, S., Williams, S., Vonbank, B., Hillis, S., Barter, D., Petnic, S., Harrison, L. H., Dumyati, G., Phipps, E. C., et al. (2018) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 2